All Posts Archives - Page 6 of 9 - EverGlade Consulting

All Posts

BARDA Issues Amendment 3 to BAA for Medical Countermeasures R&D

BARDA Issues Amendment 3 to BAA for Medical Countermeasures R&D 

The Biomedical Advanced Research and Development Authority (BARDA) has recently unveiled significant updates to its Broad Agency Announcement (BAA), emphasizing a more refined and responsive approach to public health preparedness. Amendment 3, in particular, brings crucial changes to the Areas of Interest (AOIs) that are designed to align BARDA’s efforts with the evolving landscape of global health threats. 

BARDA Issues Amendment 3 to BAA for Medical Countermeasures R&D  Read More »

Futuristic doctor with augmented reality tablet

A Comprehensive Guide to ARPA-H Funding: Process, Financial, and Technical Requirements

The Advanced Research Projects Agency for Health (ARPA-H) stands as a beacon for those within the biomedical and health sectors, propelling transformative research initiatives and breakthroughs. The pursuit of funding from ARPA-H is a monumental stride for entities operating in these domains. This guide endeavors to navigate you through the intricate application process, the financial prerequisites, and the technical stipulations pivotal for securing ARPA-H funding

A Comprehensive Guide to ARPA-H Funding: Process, Financial, and Technical Requirements Read More »

Covid Research

EverGlade Consulting Lands ModeX Therapeutics Up to $168 Million in BARDA Funding

EverGlade Consulting, a national consulting firm, has helped ModeX Therapeutics successfully secure up to $168 million in funding through a contract with the Biomedical Advanced Research and Development Authority (“BARDA”) to develop novel multispecific antibodies against viral infectious disease threats. How Funding Will Be Used The $168 million in BARDA funding will advance research and clinical trials for multispecific

EverGlade Consulting Lands ModeX Therapeutics Up to $168 Million in BARDA Funding Read More »

Wearable medical device

ARPA-H Solicits Proposals For REACT Program

Advanced Research Projects Agency (ARPA-H) Solicits Proposals for Resilient Extended Automatic Cell Therapies (REACT) Program The Advanced Research Projects Agency for Health (ARPA-H) is actively seeking innovative proposals through the Resilient Extended Automatic Cell Therapies (REACT) program, employing a Master Announcement Instruction (MAI) strategy for proposal submissions. This strategy enables proposers to tailor their submissions

ARPA-H Solicits Proposals For REACT Program Read More »

BARDA Post-Award represented with a digital drawing of virus and microscope

Effective Post-Award Management of a BARDA Contract

The Biomedical Advanced Research and Development Authority (BARDA) plays a pivotal role in the United States’ preparedness for public health emergencies. BARDA contracts support the development, procurement, and deployment of medical countermeasures critical for safeguarding public health during crises. Once awarded a BARDA contract, effective post-award management becomes paramount to ensure the successful execution of

Effective Post-Award Management of a BARDA Contract Read More »

medical countermeasures development

Guide to BARDA Funding Broad Agency Announcement Update

The Biomedical Advanced Research and Development Authority (BARDA), a USG agency that operates within the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), has recently released a new, modernized Broad Agency Announcement (BAA) with the goal of enhancing efficiency, improving responsiveness, and reducing

Guide to BARDA Funding Broad Agency Announcement Update Read More »

Female scientist in a hazmat suit researching WMD-related security challenges

DTRA BAA Weapons of Mass Destruction Amendment

DTRA BAA Outlines New Opportunity to Identify and Counter Weapons of Mass Destruction (WMD) through the Strategic Trends Research Initiative The Defense Threat Reduction Agency (DTRA) has amended its Broad Agency Announcement (BAA) to offer new funding opportunities through the Strategic Trends Research Initiative (STRI) for identifying and countering Weapons of Mass Destruction (WMD), defined

DTRA BAA Weapons of Mass Destruction Amendment Read More »

JPEO Funding - military man with gas mask and rifle

A Guide to JPEO Funding

A Guide to JPEO Funding: Application Process, Financial and Technical Requirements In the complex ecosystem of defense and homeland security, the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) holds a distinct role. This specialized office under the Department of Defense (DoD) focuses on safeguarding the United States military and its

A Guide to JPEO Funding Read More »

DIU Funding alert TacRS

DIU Funding for TacRS

In response to the increasing complexity of the space environment, the Defense Innovation Unit (DIU), has announced its pursuit of innovative commercial solutions for the development of Tactically Responsive Space (TacRS) systems. Recognizing the essential need for quick and dynamic responses to threats in space, the DoD is leading the way in advancing risk reduction

DIU Funding for TacRS Read More »

Scientist with test tubes for NIAID Funding Guide

A Guide to NIAID Funding

A Guide to NIAID Funding: Application Process, Financial and Technical Requirements The National Institute of Allergy and Infectious Diseases (NIAID) is a part of the U.S. National Institutes of Health (NIH), focusing on research related to infectious, immunologic, and allergic diseases. Securing NIAID funding can be a significant milestone for researchers and organizations in these

A Guide to NIAID Funding Read More »

Female scientist genomic sequencing

New JPEO RFI for Advanced Genomic Sequencing and In-field Sample Preparation

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) has recently issued a Request for Information (RFI) aimed at market research and planning. The primary objective of this RFI is to identify potential vendors capable of providing advanced genomic sequencing and/or associated sample preparation capabilities. The JPEO-CBRND is particularly interested in

New JPEO RFI for Advanced Genomic Sequencing and In-field Sample Preparation Read More »

Female scientist with vile and PPE for DTRA Funding Guide

A Guide to DTRA Funding

A Guide to DTRA Funding: Application Process, Financial and Technical Requirements The Defense Threat Reduction Agency (DTRA) is a U.S. Department of Defense (DoD) agency that focuses on countering weapons of mass destruction. DTRA offers numerous funding opportunities for research and development projects, but navigating the technical and financial requirements can be challenging. This guide

A Guide to DTRA Funding Read More »

Scroll to Top